Natera
Natera is a global leader in cell-free DNA testing, providing genetic testing services for reproductive health, oncology, and organ transplantation.
About
Natera is a clinical genetic testing company that develops and commercializes non-invasive prenatal testing (NIPT), oncology, and organ transplant rejection assessment tests. Their proprietary technology, based on the analysis of cell-free DNA, aims to provide highly accurate and personalized genetic information to patients and healthcare providers across various medical specialties. Teams look it up for HealthTech, MedTech, Genomics.
Frequently asked
What does Natera do?
Natera is a HealthTech company that offers Services. Teams look it up for MedTech, Genomics, Clinical Trials. It is based in Austin, United States and was founded in 2004. Public records show about 5,831 people and $55M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Natera raised?
Natera has raised a total of $55M in funding. The most recent round on record is Series E.
Where is Natera headquartered?
Natera is headquartered in Austin, United States.
When was Natera founded?
Natera was founded in 2004.
What industry does Natera operate in?
Natera operates in HealthTech, MedTech, Genomics, Clinical Trials, Oncology.
How many employees does Natera have?
Natera has approximately 5,831 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.